Risk factor identified for acute aortic dissections

(Press-News.org) People who have duplications in a region of chromosome 16 (16p13.1) that is present in approximately 1 in 1000 individuals have a 12-fold increased risk of thoracic aortic aneurysms leading to a tear in the aorta, or acute aortic dissections. An estimated 10000 people die annually from thoracic aortic aneurysms and dissections (TAAD) in the United States, where TAAD have ranked as high as the 15th leading cause of death. The study, led by genetic researchers at The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine, will be published on June 16th in the open-access journal PLoS Genetics.

There are regions of the human DNA that are deleted or duplicated, referred to as copy number variants or CNVs. These CNVs can manifest as a loss of the number of copies of a gene from two to one or as additional copies of a gene from two to three.

"We're just starting to understand copy number variants and their link to disease," said Dianna Milewicz, M.D., Ph.D., senior author and professor at UTHealth. "This is the first recurrent CNV discovered to be associated with thoracic aortic aneurysms and dissections. In addition, it is the first recurrent copy number variant to cause a predisposition to more than one disorder, neuropsychiatic conditions and thoracic aortic disease."

Duplications of the 16p13.1 region have been associated with a variety of neuropsychiatric disorders, such as schizophrenia and attention-deficit hyperactivity disorder (ADHD). One of the genes in this region is MYH11, which is known to affect the smooth muscle cell tissue in major arteries in the body, including the thoracic aorta. A weakness in the lining of the thoracic aorta, which carries blood from the heart to the rest of the body, can lead to an aneurysm and/or dissection, which can cause sudden death.

"The results of this study could affect clinical care because it appears patients with 16p13.1 duplications have an aggressive form of the thoracic aortic disease that causes aneurysms to dissect at smaller diameters," Milewicz said. "Also, once doctors are able to use the entire genome, people with duplications in 16p13.1 would need to have their aortas monitored."

### The team led by Milewicz includes researchers from UTHealth, Baylor College of Medicine, the Texas Heart Institute and GenTAC investigators from Johns Hopkins University, Weill Medical College of Cornell University and the National Heart, Lung and Blood Institute.

FINANCIAL DISCLOSURE: The following sources provided funding for these studies: National Institute of Health grants R21 HL091509, P50HL083794-01 (DMM), and RO1 HL62594 (DMM); the Vivian L. Smith Foundation; the TexGen Foundation; and the Doris Duke Charitable Trust grant (DMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

COMPETING INTERESTS: The authors have declared that no competing interests exist.

CITATION: Kuang S-Q, Guo D-C, Prakash SK, McDonald M-LN, Johnson RJ, et al. (2011) Recurrent Chromosome 16p13.1 Duplications Are a Risk Factor for Aortic Dissections. PLoS Genet 7(6): e1002118. doi:10.1371/journal.pgen.1002118

CONTACT:
Deborah Mann Lake
Senior Media Relations Specialist
The University of Texas Health Science Center at Houston
713-500-3304 office
281-658-9024 cell
713-500-3030 media hotline

Disclaimer This press release refers to an upcoming article in PLoS Genetics. The release is provided by journal staff, or by the article authors and/or their institutions. Any opinions expressed in this release or article are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information. About PLoS Genetics PLoS Genetics (http://www.plosgenetics.org) reflects the full breadth and interdisciplinary nature of genetics and genomics research by publishing outstanding original contributions in all areas of biology. All works published in PLoS Genetics are open access. Everything is immediately and freely available online throughout the world subject only to the condition that the original authorship and source are properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License. About the Public Library of Science The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org.